Viewing Study NCT00461162



Ignite Creation Date: 2024-05-05 @ 5:30 PM
Last Modification Date: 2024-10-26 @ 9:32 AM
Study NCT ID: NCT00461162
Status: COMPLETED
Last Update Posted: 2014-08-18
First Post: 2007-04-13

Brief Title: Dyspnea Self-Management Internet or Face-to-Face
Sponsor: University of California San Francisco
Organization: University of California San Francisco

Study Overview

Official Title: Dyspnea Self-Management Internet or Face-to-Face
Status: COMPLETED
Status Verified Date: 2014-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Chronic obstructive pulmonary disease including emphysema and chronic bronchitis is the fourth most common cause of death and the second leading cause of disability in the United States COPD is estimated to be responsible for more than 134 million physician visits and 13 of hospitalizations nationally These hospitalizations are usually caused by acute exacerbations characterized by an increase in symptoms including dyspnea or shortness of breath SOB cough wheezing and sputum production The significant disability for people with COPD is primarily due to the symptom of dyspnea shortness of breath that affects an individuals quality of life more than does the physiological impairment Despite optimal medical and pharmacological therapy most people with COPD continue to suffer from chronic and progressive dyspnea and other symptoms of cough and fatigue

We have previously shown that an individualized face-to-face dyspnea self-management program was effective in improving dyspnea with activities of daily living ADL physical functioning and self-efficacy for managing dyspnea Using an experimental longitudinal design the i-DSMP will be compared to the Face-to-Face Dyspnea Self-Management Program f-DSMP and to an Attention Control AC intervention
Detailed Description: At the present time education about symptom management for patients and treatments including exercise are primarily provided within structured and episodic pulmonary rehabilitation PR programs These PR programs are of short duration are available for only a small percentage of people because they are expensive and not covered by all third party payers and often require travel by patients who are disabled Given estimates of 10 to 24 million US adults with COPDmost of who would benefit from PR only less than 01 can be accommodated at any given time In the US the maintenance or exercise programs following PR are not reimbursed and therefore not available for most patients

A number of self-management programs have been tested in multiple chronic diseasesbut there has been less study of self-management programs for patients with COPD The few self-management programs for COPD that include only education and limited skills training have not significantly improved symptoms Home-based PR and self-management programs with nurse home visits have been studied and provide a less costly and accessible alternative Clearly there is a growing need for more accessible and alternative avenues for providing ongoing support and therapy for COPD patients

The Internet provides a new exciting delivery channel that offers patients with disabilities an opportunity for greater involvement in health care decision-making and unparalleled opportunities to learn inform and communicate with one another and for health care providers to support patients self-management efforts Several Internet-based studies for other chronic illnesses have increased self-efficacy for symptom management perception of available support and patients involvement in health care decision making while reducing symptoms and health care costs The only published study evaluating the use of the internet to support self-management in COPD patients was our pilot study for this proposal Our study demonstrated an improvement in both self-efficacy and dyspnea with daily activities measures This study will expand on the findings of our pilot study

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
R01NR008938-01A2 NIH None httpsreporternihgovquickSearchR01NR008938-01A2
R01NR008938 NIH None None